“…In theory, the CRISPR/Cas protein scans the PAM sequence, and sgRNA recognises target loci and activates endonuclease activity to cleave specific sites. However, cleavage efficiency varies greatly among different target sites and/or cell lines [14], [21], [27], [28], [51], [78], [87], [98], [99], [103], [115], [117], [122], [125], suggesting that several features may influence the binding and cutting efficacy of the sgRNA-Cas complex. Numerous studies have revealed that gRNA sequence features (sequence composition, nucleotide position, GC content), genetic and epigenetic features (chromatin accessibility, gene expression) and energetics properties (RNA secondary structure, melting temperature, free energy) all contribute to gRNA efficacy.…”